These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25399255)

  • 1. A network biology workflow to study transcriptomics data of the diabetic liver.
    Kutmon M; Evelo CT; Coort SL
    BMC Genomics; 2014 Nov; 15(1):971. PubMed ID: 25399255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the therapeutic mechanisms of Xiao-Ke-An in treatment of type 2 diabetes in mice by a Fangjiomics approach.
    Yang ZZ; Liu W; Zhang F; Li Z; Cheng YY
    Acta Pharmacol Sin; 2015 Jun; 36(6):699-707. PubMed ID: 25960133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMap analysis identifies Atractyloside as a potential drug candidate for type 2 diabetes based on integration of metabolomics and transcriptomics.
    Li H; Shi X; Jiang H; Kang J; Yu M; Li Q; Yu K; Chen Z; Pan H; Chen W
    J Cell Mol Med; 2020 Jul; 24(13):7417-7426. PubMed ID: 32469143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analyses to reconstruct microRNA-mediated regulatory networks in mouse liver using high-throughput profiling.
    Hsu SD; Huang HY; Chou CH; Sun YM; Hsu MT; Tsou AP
    BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S12. PubMed ID: 25707768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes.
    Liu XL; Ming YN; Zhang JY; Chen XY; Zeng MD; Mao YM
    Exp Mol Med; 2017 Jan; 49(1):e283. PubMed ID: 28082742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis of transcriptomics, proteomics, and metabolomics data of white adipose and liver tissue of high-fat diet and rosiglitazone-treated insulin-resistant mice identified pathway alterations and molecular hubs.
    Meierhofer D; Weidner C; Sauer S
    J Proteome Res; 2014 Dec; 13(12):5592-602. PubMed ID: 25287014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic network topology reveals transcriptional regulatory signatures of type 2 diabetes.
    Zelezniak A; Pers TH; Soares S; Patti ME; Patil KR
    PLoS Comput Biol; 2010 Apr; 6(4):e1000729. PubMed ID: 20369014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems biology approach identifies key regulators and the interplay between miRNAs and transcription factors for pathological cardiac hypertrophy.
    Recamonde-Mendoza M; Werhli AV; Biolo A
    Gene; 2019 May; 698():157-169. PubMed ID: 30844478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A strategy to detect metabolic changes induced by exposure to chemicals from large sets of condition-specific metabolic models computed with enumeration techniques.
    Fresnais L; Perin O; Riu A; Grall R; Ott A; Fromenty B; Gallardo JC; Stingl M; Frainay C; Jourdan F; Poupin N
    BMC Bioinformatics; 2024 Jul; 25(1):234. PubMed ID: 38992584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications.
    Sengupta U; Ukil S; Dimitrova N; Agrawal S
    PLoS One; 2009 Dec; 4(12):e8100. PubMed ID: 19997558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy.
    Platania CBM; Leggio GM; Drago F; Salomone S; Bucolo C
    Biochem Pharmacol; 2018 Dec; 158():13-26. PubMed ID: 30222965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targets and candidate agents for type 2 diabetes treatment with computational bioinformatics approach.
    Wang Q; Zhao Z; Shang J; Xia W
    J Diabetes Res; 2014; 2014():763936. PubMed ID: 25401107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering the transcription factor-microRNA-target gene regulatory network associated with graphene oxide cytotoxicity.
    Farahani M; Rezaei-Tavirani M; Zali H; Arefi Oskouie A; Omidi M; Lashay A
    Nanotoxicology; 2018 Nov; 12(9):1014-1026. PubMed ID: 30325693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of microRNA and gene expression profiles reveals a functional regulatory module associated with liver fibrosis.
    Chen W; Zhao W; Yang A; Xu A; Wang H; Cong M; Liu T; Wang P; You H
    Gene; 2017 Dec; 636():87-95. PubMed ID: 28919164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between circadian rhythm related genes, type 2 diabetes, and cancer: Insights from metanalysis of transcriptomics data.
    Barbosa Vieira TK; Jurema da Rocha Leão M; Pereira LX; Alves da Silva LC; Pereira da Paz BB; Santos Ferreira RJ; Feitoza CC; Fernandes Duarte AK; Barros Ferreira Rodrigues AK; Cavalcanti de Queiroz A; Fireman de Farias K; Del Vechio Koike B; de Sales Marques C; Alberto de Carvalho Fraga C
    Mol Cell Endocrinol; 2021 Apr; 526():111214. PubMed ID: 33610641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analysis of the gene expression profile and DNA methylation profile of obese patients with type 2 diabetes.
    Shen J; Zhu B
    Mol Med Rep; 2018 Jun; 17(6):7636-7644. PubMed ID: 29620215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Path2enet: generation of human pathway-derived networks in an expression specific context.
    Droste C; De Las Rivas J
    BMC Genomics; 2016 Oct; 17(Suppl 8):731. PubMed ID: 27801297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Search for Master Regulators in Walking Cancer Pathways.
    Kel AE
    Methods Mol Biol; 2017; 1613():161-191. PubMed ID: 28849562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CyTargetLinker: a cytoscape app to integrate regulatory interactions in network analysis.
    Kutmon M; Kelder T; Mandaviya P; Evelo CT; Coort SL
    PLoS One; 2013; 8(12):e82160. PubMed ID: 24340000
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.